MindWalk Holdings Corp.

NasdaqCM:HYFT Stock Report

Market Cap: US$91.9m

MindWalk Holdings Management

Management criteria checks 1/4

MindWalk Holdings' CEO is Jennifer Bath, appointed in Feb 2018, has a tenure of 8.33 years. total yearly compensation is CA$1.16M, comprised of 75.7% salary and 24.3% bonuses, including company stock and options. directly owns 1% of the company’s shares, worth $921.52K. The average tenure of the management team and the board of directors is 1.4 years and 1.9 years respectively.

Key information

Jennifer Bath

Chief executive officer

CA$1.2m

Total compensation

CEO salary percentage75.75%
CEO tenure8.3yrs
CEO ownership1.0%
Management average tenure1.4yrs
Board average tenure1.9yrs

Recent management updates

Recent updates

Analysis Article • Jan 08

MindWalk Holdings Corp.'s (NASDAQ:HYFT) P/S Is Still On The Mark Following 38% Share Price Bounce

MindWalk Holdings Corp. ( NASDAQ:HYFT ) shareholders have had their patience rewarded with a 38% share price jump in...
Seeking Alpha • Oct 17

MindWalk Holdings: Repositioned TechBio Platform With Early LensAI Proof Points

Summary MindWalk Holdings (HYFT) has pivoted to an asset-light, AI-driven techbio platform, leveraging its HYFT and LensAI technologies for in silico drug discovery. LensAI's early successes include a dual-action GLP-1 agonist and a universal dengue vaccine candidate, highlighting HYFT's practical potential and commercial promise. HYFT reported record quarterly sales, improved margins, and a strengthened balance sheet post-divestiture. At an $75 million valuation, HYFT remains undervalued relative to  other techbio players; I assign a Buy rating based on its platform, partnerships, and growth outlook. Read the full article on Seeking Alpha
Analysis Article • Jun 24

Even With A 72% Surge, Cautious Investors Are Not Rewarding ImmunoPrecise Antibodies Ltd.'s (NASDAQ:IPA) Performance Completely

Despite an already strong run, ImmunoPrecise Antibodies Ltd. ( NASDAQ:IPA ) shares have been powering on, with a gain...
User avatar
New Narrative • May 05

AI Driven Partnerships Will Open New Biotech Opportunities

Strategic partnerships and tech collaborations are anticipated to boost revenue streams, improve net margins, and enhance operational efficiency.
Analysis Article • May 04

ImmunoPrecise Antibodies Ltd.'s (NASDAQ:IPA) Shares Leap 28% Yet They're Still Not Telling The Full Story

ImmunoPrecise Antibodies Ltd. ( NASDAQ:IPA ) shareholders would be excited to see that the share price has had a great...
Analysis Article • Apr 22

Will ImmunoPrecise Antibodies (NASDAQ:IPA) Spend Its Cash Wisely?

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Analysis Article • Jan 17

Even With A 30% Surge, Cautious Investors Are Not Rewarding ImmunoPrecise Antibodies Ltd.'s (NASDAQ:IPA) Performance Completely

ImmunoPrecise Antibodies Ltd. ( NASDAQ:IPA ) shares have had a really impressive month, gaining 30% after a shaky...
Analysis Article • Nov 24

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Stock's 45% Dive Might Signal An Opportunity But It Requires Some Scrutiny

ImmunoPrecise Antibodies Ltd. ( NASDAQ:IPA ) shareholders that were waiting for something to happen have been dealt a...
Seeking Alpha • Sep 14

ImmunoPrecise Antibodies reports FQ1 results

ImmunoPrecise Antibodies press release (NASDAQ:IPA): FQ1 Revenue of C$4.7M (+2.2% Y/Y). As of July 31, 2022, the company held cash of C$19.2M as compared to C$30.0M as of April 30, 2022, and had working capital of C$21.7M. The company’s internal forecast indicates the cash on hand will sustain its existing operations for at least 12 months.

CEO Compensation Analysis

How has Jennifer Bath's remuneration changed compared to MindWalk Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Jan 31 2026n/an/a

-CA$12m

Oct 31 2025n/an/a

-CA$30m

Jul 31 2025n/an/a

-CA$30m

Apr 30 2025CA$1mCA$877k

-CA$30m

Jan 31 2025n/an/a

-CA$47m

Oct 31 2024n/an/a

-CA$28m

Jul 31 2024n/an/a

-CA$27m

Apr 30 2024CA$1mCA$732k

-CA$26m

Jan 31 2024n/an/a

-CA$14m

Oct 31 2023n/an/a

-CA$16m

Jul 31 2023n/an/a

-CA$21m

Apr 30 2023CA$2mCA$714k

-CA$27m

Jan 31 2023n/an/a

-CA$26m

Oct 31 2022n/an/a

-CA$25m

Jul 31 2022n/an/a

-CA$23m

Apr 30 2022CA$2mCA$649k

-CA$17m

Jan 31 2022n/an/a

-CA$17m

Oct 31 2021n/an/a

-CA$15m

Jul 31 2021n/an/a

-CA$10m

Apr 30 2021CA$2mCA$503k

-CA$7m

Jan 31 2021n/an/a

-CA$3m

Oct 31 2020n/an/a

-CA$3m

Jul 31 2020n/an/a

-CA$3m

Apr 30 2020CA$673kCA$488k

-CA$5m

Compensation vs Market: Jennifer's total compensation ($USD830.44K) is about average for companies of similar size in the US market ($USD640.99K).

Compensation vs Earnings: Jennifer's compensation has increased whilst the company is unprofitable.

CEO

Jennifer Bath

8.3yrs
Tenure
CA$1,157,862
Compensation

Dr. Jennifer Lynne Bath, Ph D, has been the Chief Executive Officer and President of MindWalk Holdings Corp. (formerly known as ImmunoPrecise Antibodies Ltd.) since February 21, 2018. Dr. Bath served as th...

Leadership Team

NamePositionTenureCompensationOwnership
Jennifer Bath
CEO, President & Non-Independent Director8.3yrsCA$1.16m1%
$ 921.5k
Kari Graber
Vice President of Commercial Services8.1yrsCA$393.89k0.0014%
$ 1.3k
Shuji Sato
Vice President of Innovative Solutionsno dataCA$290.05kno data
Richard Areglado
Chief Financial Officerless than a yearno data0.053%
$ 49.0k
Dirk Hyfte
Chief Technology Officer1.4yrsno datano data
Frederic Chabot
Head of Corporate Development1.4yrsno datano data
Ingrid Brands
Chief Innovation & Strategy Officer1.4yrsno datano data
Thomas Lynch
Chief Business Officerless than a yearno data0.083%
$ 75.9k
Lori Anderson
Vice President of Brand Marketing and Creativeno datano data0.0050%
$ 4.6k
1.4yrs
Average Tenure

Experienced Management: HYFT's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Jennifer Bath
CEO, President & Non-Independent Director8.1yrsCA$1.16m1%
$ 921.5k
Jonathan Lieber
Independent Director1yrno data0.016%
$ 14.4k
Dirk Witters
Independent Chairman of the Board2.8yrsCA$99.22k0.0039%
$ 3.6k
Jeff Fried
Member of Advisory Boardless than a yearno datano data
1.9yrs
Average Tenure

Experienced Board: HYFT's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/05 19:56
End of Day Share Price 2026/06/05 00:00
Earnings2026/01/31
Annual Earnings2025/04/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

MindWalk Holdings Corp. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tania Armstrong-WhitworthATB Cormark Historical (Cormark Securities)
Robert WassermanBenchmark Company
Swayampakula RamakanthH.C. Wainwright & Co.